Discover 1,106 paid clinical trials in Salt Lake City, Utah. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
There are a wide variety of studies currently listed in Salt Lake City, focusing on conditions such as autism, celiac disease, and osteoporosis. The city's leading medical research institutions are actively recruiting participants, providing access to cutting-edge treatments and therapies for both healthy volunteers interested in paid clinical trials and individuals in need of studies for specific health conditions.
Filter
2
Filter results
Results: 1,106
Featured
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
for
Non-Small Cell Lung Cancer, c-MET
Location: Ogden UT, Reno NV, Chandler AZ, Spokane WA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06568939
Phase 2, Recruiting
Featured
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Location: Ogden UT, Las Vegas NV, Littleton CO, Albuquerque NM,
Sponsor: 89bio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06318169
Phase 3, Recruiting
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for
Chronic Granulomatous Disease (CGD)
Location: Salt Lake City UT, Boise ID, Cheyenne WY, Denver CO,
Sponsor: Ensoma
Sex: All
Age: 0+
Code: NCT06605378
Recruiting
Active & Responsive
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
for
Sjögren, Sjogren Disease, Sjogren's Syndrome
Location: Salt Lake City UT, Plano TX, Webster TX, Memphis TN,
Sponsor: Cullinan Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT07041099
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
for
HIV-1-infection
Location: Salt Lake City UT, Denver CO, Sante Fe NM,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT07645287
Phase 2, Recruiting
Active & Responsive
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
for
HIV Infections
Location: Salt Lake City UT, Las Vegas NV, Santa Fe NM,
Sponsor: ViiV Healthcare
Sex: All
Age: 12+
Code: NCT07650916
Phase 3, Recruiting
Active & Responsive
A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
for
Solid Tumor
Location: West Valley City UT, Duarte CA, Palo Alto CA,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18+
Code: NCT06384807
Phase 1, Phase 2, Recruiting
Active & Responsive
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
for
Major Depressive Disorder (MDD),
Location: Salt Lake City UT, Las Vegas NV, Denver CO, Chino CA,
Sponsor: ACADIA Pharmaceuticals Inc.
Sex: All
Age: 18 - 65
Code: NCT07284667
Phase 2, Recruiting
Active & ResponsiveNew
Using Gaze to Enable Head-neck Movements in Patients With Head Drop
for
Amyotrophic Lateral Sclerosis & Other Neuromuscular Disorders
Location: Salt Lake City UT
Sponsor: University of Utah
Sex: All
Age: 18+
Code: NCT07836751
Recruiting
Active & Responsive
Behavioral Treatment for Nightmares in REM Sleep Behavior Disorder
for
Nightmare,
Location: Salt Lake City UT
Sponsor: University of Utah
Sex: All
Age: 18+
Code: NCT06441864
Recruiting
Active & Responsive
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Location: Salt Lake City UT, Denver CO, Reno NV, Albuquerque NM,
Sponsor: Tempus AI
Sex: All
Age: 18+
Code: NCT06911632
Recruiting
Active & Responsive
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
for
Treatment Resistant Depression
Location: Salt Lake City UT, Los Angeles CA, Costa Mesa CA,
Sponsor: LivaNova
Sex: All
Age: 18+
Code: NCT03887715
Recruiting
Active & Responsive
A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease
for
Degenerative Disc Disease
Location: Salt Lake City UT, San Diego CA, Phoenix AZ,
Sponsor: DiscGenics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07254806
Phase 3, Recruiting
Active & Responsive
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
for
Opioid Use Disorder, Opioid Use Disorder, Moderate,
Location: Salt Lake City UT, Cape Girardeau MO, Chicago IL,
Sponsor: T. John Winhusen, PhD
Sex: All
Age: 18+
Code: NCT06651177
Phase 2, Recruiting
Active & Responsive
A Novel Digital Music-based Autonomous Personalized Walking Intervention to Improve Gait and Walking Automaticity in Parkinson Disease
for
Parkinson's Disease (PD)
Location: Salt Lake City UT, St Louis MO, Boston MA
Sponsor: Boston University Charles River Campus
Sex: All
Age: 40+
Code: NCT07705373
Recruiting
Active & Responsive
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
for
Type 1 Diabetes Mellitus
Location: Salt Lake City UT, Aurora CO, San Francisco CA,
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 8 - 45
Code: NCT07142252
Phase 2, Recruiting
Active & Responsive
A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease
for
Still´s Disease
Location: Salt Lake City UT, Portland OR
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 1+
Code: NCT07203001
Phase 2, Recruiting
Active & Responsive
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
for
Fabry Disease
Location: Salt Lake City UT, Phoenix AZ, Iowa City IA,
Sponsor: Chiesi Farmaceutici S.p.A.
Sex: All
Age: 2 - 17
Code: NCT06328608
Phase 2, Phase 3, Recruiting
Active & Responsive
Mechanisms of Rumination Change in Adolescent Depression